Document is current
Any future updates will be listed below
-
Authors
Su, Changjun
Shen, Jiucheng
Guo, Kaida
Wang, Jing
Wang, Zhijun
Gao, Shiyuan
Wang, Qiaojun
Han, Fei
Zhang, Weijia
Ye, Hui
Li, Xiang
Zhang, Ruolin
Chen, Rui
-
Funding
Funding for this research was provided by:
Ignis Therapeutics (Suzhou) Limited
- License Information
-
More Information
Article History
Received: 12 May 2026
Accepted: 15 June 2026
First Online: 9 July 2026
Declarations
:
: Weijia Zhang, Hui Ye, Xiang Li, and Ruolin Zhang are employees of Ignis Therapeutics (Shanghai) Limited. All other authors; Changjun Su, Jiucheng Shen, Kaida Guo, Jing Wang, Zhijun Wang, Shiyuan Gao, Qiaojun Wang, Fei Han and Rui Chen declare no conflicts of interest.
: The parent randomized clinical trial was approved by the institutional review board of Peking University Sixth Hospital ([2023] Ethics Review No. 22-1) and by the 25 independent ethics committees at all other participating sites. The ethical approval numbers for each study site are summarized in Table .
